Cancer Genetic Consultation and Anxiety in Healthy Consultees

Psychology and Health

Volumn 14, Issue 3, 1999, Pages 379-390

  Julian Reynier, Claire ^a   Eisinger, François ^b   Chabal, Françoise ^a   Aurran, Yvette ^a   Bignon, Yves Jean ^c   Machelard Roumagnac, Martine ^d   Maugard, Christine ^e   Noguès, Catherine ^f   Vennin, Philippe ^g   Sobol, Hagay ^b  

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c CENTRE JEAN PERRIN   (France)

^d INSTITUT CLAUDIUS REGAUD   (France)

^e CENTRE RENÉ GAUDUCHEAU   (France)

^f CENTRE RENÉ HUGUENIN   (France)

^g CENTRE OSCAR LAMBRET   (France)

Author keywords

Anxiety; Cancer genetics; Depression; Evaluation; Psycho social epidemiology. 91 22; Risk

Indexed keywords

EID: 0033448056     PISSN: 08870446     EISSN: None     Source Type: Journal    
DOI: 10.1080/08870449908407335     Document Type: Article

References (51)

1. Andrieu, N., Clavel, F., Auquier, A., Gairard, B., Piana, L., Bremond, A., Lansac, J., Flamant, R. and Renaud, R. (1993). Variations in the risk of breast cancer associated with a family history of breast cancer according to age at onset and reproductive factors. Journal of Clinical Epidemiology, 46, 973-980.
2. Bruchon-Schweitzer, M-L. and Paulhan, I. (1993). Inventaire d'anxiété état-trait-Forme Y. Adaptation française de Spielberger, C. Paris: Editions du Centre de Psychologie Appliquée.
3. Compas, B.E., Worsham, N.L., Ey, S. and Howell, D.C. (1996). When mom or dad has cancer: II Coping, cognitive appraisals, and psychological distress in children of cancer patients. Health Psychology, 15, 167-175.
4. Devesa, S.S., Blot, W.J., Miller, S.B.A., Tarone, R.E. and Fraumeni, J.F. (1995). Recent cancer trends in the United States. Journal of the National Cancer Institute, 87, 175-182.
5. Eaton, W.W. and Kessler, L.G. (1981). Rates of symptoms of depression in a national sample. American Journal of Epidemiology, 114, 528-538.
6. Eisinger, F., Julian-Reynier, C., Chabal, F., Luquet, C., Moatti, J. and Sobol, H. (1997). Is daily chemoprevention an acceptable strategy for dealing with hereditary breast/ovarian cancer risk? Journal of the National Cancer Institute, 10, 731.
7. Eisinger, F., Thouvenin, D., Bignon, Y.J., Cuisenier, J., Feingold, J., Hoerni, B., Lasset, C., Lyonnet, D., Maraninchi, D., Marty, M., Mattei, F., Sobol, H., Maugard-Louboutin, C., Nogues, C., Pujol, H. and Philip, T. (1995). Réflexions sur l'organisation des consultations d'oncogénétique (première étape vers la publication de bonnes pratiques cliniques). Bulletin du Cancer, 82, 865-878.
8. Evans, D.G. (1995). Genetic testing for cancer predisposition: need and demand. Journal of Medical Genetics, 32, 161.
9. Fishel, R. and Kolodner, R.D. (1995). Identification of mismatch repair genes and their role in the development of cancer. Current Opinion in Genetics and Development, 5, 382-395.
10. Freedman, T.G. (1997). Genetics susceptibility testing: a therapeutic illusion? Cancer, 79, 2063-2065.
11. Fuhrer, R. and Rouillon, F. (1989). La version française de l'échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l'échelle d'autoévaluation. Psychiatrie et Psychobiologie, 4, 163-166.
12. Futreal, P.A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L.M., Haugen-Strano, A., Swensen, J. and Miki, Y. (1994). BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120-122.
13. Gauthier, J. and Bouchard, S. (1993). Adaptation Canadienne-Française de la forme révisée du State Trait Anxiety Inventory de Spielberger. Revue Canadienne des Sciences du Comportement, 25, 559-589.
14. Green, J., Murton, F. and Statham, H. (1993). Psychosocial issues raised by a familial ovarian cancer register. Journal of Medical Genetics, 30, 575-579.
15. Guillem, J.G., Forde, K.A., Treat, M.R., Neugut, A.I., O'Toole, K.M. and Diamond, B.E. (1992). Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. Diseases of the Colon & Rectum, 35, 523-529.
16. Hallowell, N., Green, J.M., Statham, H., Murton, F. and Richards, M.P.M. (1997). Recall of numerical risk estimates and counsellees' perceptions of the importance of risk information following genetic counselling for breast and ovarian cancer. Psychology, Health and Medicine, 2, 149-159.
17. Hill, C., Koscielny, S., Doyon, F. and Benhamou (Eds) (1993). Evolution de la mortalité par cancer en France 1950-1990. Paris: Les Editions INSERM.
18. Hodgson, S.V. and Maher, E.R. (Eds) (1993). A practical guide to human cancer genetics Cambridge: Cambridge university press.
19. Hoskins, I.A. (1989). Genetic counselling for cancer patients and their families. Oncology, 3, 84-92.
20. Houlston, R., Bourne, T.H., Davies, A., Whitehead, M.I., Campbell, S., Collins, W.P. and Slack, J. (1992a). Use of family history in a screening clinic for familial ovarian cancer. Gynecologic Oncology, 47, 247-252.
21. Houlston, R.S., Lemoine, L., McCarter, E., Harrington, S., MacDermott, K., Hinton, J., Berger, L. and Slack, J. (1992b). Screening and genetic counselling for relatives of patients with breast cancer in a family cancer clinic. Journal of Medical Genetics, 29, 691-694.
22. Houlston, R.S., Murday, V., Harocopos, C., Williams, C.B. and Slack, J. (1990). Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. British Medical Journal, 301, 366-368.
23. Julian-Reynier, C., Eisinger, F., Chabal, F., Aurran, Y., Noguès, C., Vennin, P., Bignon, Y.J., Machelard-Roumagnac, M., Maugard-Louboutin, C., Serin, D., Versini, S., Mercuri, M. and Sobol, H. (1996). Cancer genetic clinics: target population and expectations. European Journal of Cancer, 32A, 398-403.
24. Lee, J.M. (1993). Screening and informed consent. New England Journal of Medicine, 328, 438-440.
25. Lerman, C. and Croyle, R. (1994). Psychological issues in genetic testing for breast cancer susceptibility. Archives of Internal Medicine, 154, 609-616.
26. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulmore, C., Snyder, C., Lemon, S.J., Conway, T., Tonin, P., Lenoir, G. and Lynch, H. (1996a). BRCA1 testing in families with hereditary breast-ovarian cancer. Journal of the American Medical Association, 275, 1885-1892.
27. Lerman, C., Schwartz, M.D., Miller, S.M., Daly, M., Sands, C. and Rimer, B.K. (1996b). A randomized trial of breast cancer risk counselling: interacting effects of counselling, educational level, and coping style. Health Psychology, 15, 75-83.
28. McKinlay, J.B., Potter, D.A. and Feldman, H.A. (1996). Non-medical influences on medical decision-making. Social Science & Medicine, 42, 769-776.
29. Michie, S., McDonald, V. and Marteau, T. (1996). Understanding responses to predictive genetic testing: a grounded theory approach. Psychology and Health, 11, 455-470.
30. Michie, S., Marteau, T.M. and Bobrow, M. (1997). Genetic counselling: the psychological impact of meeting patients expectations. Journal of Medical Genetics, 34, 237-241.
31. Miki, Y., Swenson, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, Z., Gholami, D., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, P., Narod, S., Bristow, P.K., Norris, F.H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J.-C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Golgar, D., Wiseman, R., Kamb, A. and Skolnick, M.H. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
32. Murday, V. (1994). Genetic counselling in the cancer family clinic. European Journal of Cancer, 3A, 2012-2015.
33. Ong, L.M.L., De Haes, J.C.J.M., Hoos, A.M. and Lammes, F.B. (1995). Doctor-Patient communication: a review of the literature. Social Science & Medicine, 40, 903-918.
34. Seidenfeld, M.J. and Antley, R.M. (1981). Genetic counselling: A comparison of counselee's genetic knowledge before and after (part III). American Journal of Medical Genetics, 10, 107-112.
35. Sobol, H., Bignon, Y.-J., Cuisenier, J., Lyonnet, D., Noguès, C., Eisinger, F. and Groupe Génétique et Cancer de la FNCLCC (1995). Le groupe Génétique et Cancer de la FNCLCC. Les consultations d'oncogénétique en 1994, analyse de l'activité: enquête sur 203 consultations. In M. Boiron (Ed.), Eurocancer 95 (pp. 43-46). Paris: John Libbey Eurotext.
36. Sobol, H., Mazoyer, S., Narod, S., Smith, S., Black, D.M., Kerbrat, P., Jamot, B., Solomon, E., Ponder, B.A.J. and Guerin, D. (1992). Genetic heterogeneity of early-onset familial breast cancer. Human genetics, 89, 381-383.
37. Spielberger, C. (1985). Assessment of state and trait anxiety: Conceptual and methodological issues. The Southern Psychologist, 2, 6-16.
38. Stefanek, M.E. (1992). Psychological distress and breast cancer screening among women at high risk: where are we? Journal of the National Cancer Institute, 84, 22.
39. Struewing, J.P., Hartge, P., Wacholder, S., Baker, S.M., Berlin, M., McAdams, M., Timmerman, M.M., Brody, L.C. and Tucker, M.A. (1997). The risk of cancer associated with specific mutations or BRCA1 and BRCA2 among ashkenazi Jews. New England Journal of Medicine, 336, 1401-1407.
40. Thompson, J.A., Wiesner, G.L., Sellers, T.A., Vachon, C., Ahrens, M., Potter, J.D., Sumpmann, M. and Kersey, J. (1995). Genetic services for familial cancer patients: a survey of National Cancer Institute Cancer Centers. Journal of the National Cancer Institute, 87, 1446-1455.
41. Valdimarsdottir, H.B., Bovbjerg, D.A., Kash, K.M., Holland, J.C., Osborne, M.P. and Miller, D.G. (1995). Psychological distress in women with a familial risk of breast cancer. Psychologica-Oncology, 4, 133-141.
42. Vernon, S.W., Vogel, V.G., Halabi, S. and Bondy, M.L. (1993). Factors associated with perceived risk of breast cancer among women attending a screening program. Breast Cancer Research and Treatment, 28, 137-144.
43. Vlek, C. (1987). Risk assessment, risk perception and decision making about courses of action involving genetic risks. Birth Defects Original Articles Series, 23, 171-207.
44. Wardle, F.J., Collins, W, Pernet, A.L., Whitehead, M.I., Bourne, T.H. and Campbell, S. (1993). Psychological impact of screening for familial ovarian cancer. Journal of the National Cancer Institute, 85, 653-657.
45. Watson, M., Murday, V., Lloyd, S., Ponder, B., Averill, D. and Eeles, R. (1995). Genetic testing in breast/ovarian cancer (BRCA1) families. The Lancet, 346, 583.
46. Welch, A.S., Wadsworth, M.E. and Compas, B.E. (1996). Adjustement of children and adolescents to parental cancer: parents' and children's perspectives. Cancer, 77, 1409-1418.
47. Weller, A. and Hener, T. (1993). Invasiveness of medical procedures and state anxiety in women. Behavioral Medicine, 19, 60-65.
48. Wertz, D.C. (1997). Society and the not-so-new genetics: what are we afraid of? Some future predictions from a social scientist. The Journal of Contemporary Health Law and Policy, 13, 299-346.
49. Winefield, H. and Weinman, J. (1996). Communication in health care: process and outcomes. Psychology & Health, 11, 769-771.
50. Winett, R.A., Anderson, E.S., Desiderato, L.L., Solomon, L.J., Perry, M., Kelly, J.A., Sikkema, K.J., Roffman, R.A., Norman, A.D., Lombard, D.N. and Lombard, T.N. (1995). Enhancing social diffusion theory as a basis for prevention intervention: a conceptual and strategic framework. Applied & Preventive Psychology, 4, 233-245.
51. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs, P., Hashim, Y., Smith, A., Connor, F., Arason, A., Gudmundsson, J., Ficenec, D., Kelsell, D., Ford, D., Tonin, P., Bishop, T., Spurr, N.K., Ponder, B.A.J., Eeles, R., Peto, J., Devilee, P., Cornelisse, C., Lynch, H., Narod, S., Lenoir, G., Egilsson, V., Barkadottir, R.B., Easton, D.F., Bentley, D.R., Futreal, P.A., Ashworth, A. and Stratton, M.R. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789-792.